Market Cap ₹2451 Cr.
Stock P/E 49.5
P/B 6.4
Current Price ₹179
Book Value ₹ 27.8
Face Value 1
52W High ₹199
Dividend Yield 0.25%
52W Low ₹ 79.2
Artemis Medicare Services Ltd manages and operates multi-speciality hospitals in India and across the world. The company offers scientific and surgical intervention; and inpatient and outpatient offerings. It additionally operates Artemis Hospital, a 395 bed multi-speciality health facility placed in Gurugram, India. The business enterprise changed into incorporated in 2004 and is based in Gurugram, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 144 | 149 | 167 | 187 | 187 | 195 | 210 | 225 | 219 | 225 |
Other Income | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 2 |
Total Income | 145 | 151 | 170 | 189 | 189 | 198 | 211 | 227 | 221 | 227 |
Total Expenditure | 126 | 132 | 148 | 164 | 162 | 170 | 182 | 191 | 186 | 187 |
Operating Profit | 19 | 18 | 22 | 25 | 27 | 28 | 29 | 37 | 34 | 40 |
Interest | 3 | 4 | 4 | 5 | 5 | 5 | 7 | 8 | 8 | 9 |
Depreciation | 6 | 6 | 7 | 7 | 8 | 9 | 9 | 10 | 10 | 11 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 10 | 8 | 11 | 13 | 13 | 14 | 13 | 19 | 16 | 20 |
Provision for Tax | 4 | -5 | 2 | 4 | 3 | 3 | 3 | 5 | 5 | 6 |
Profit After Tax | 6 | 13 | 8 | 9 | 10 | 11 | 10 | 14 | 12 | 14 |
Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 |
Profit After Adjustments | 6 | 13 | 8 | 9 | 10 | 11 | 10 | 14 | 12 | 14 |
Adjusted Earnings Per Share | 0.5 | 1 | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 1 | 0.9 | 1 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 547 | 565 | 408 | 555 | 737 | 879 |
Other Income | 4 | 5 | 4 | 5 | 7 | 7 |
Total Income | 551 | 570 | 412 | 560 | 745 | 886 |
Total Expenditure | 483 | 504 | 373 | 488 | 643 | 746 |
Operating Profit | 68 | 66 | 39 | 71 | 101 | 140 |
Interest | 11 | 13 | 13 | 12 | 20 | 32 |
Depreciation | 20 | 23 | 22 | 22 | 31 | 40 |
Exceptional Income / Expenses | 0 | 0 | 3 | 0 | 0 | 0 |
Profit Before Tax | 37 | 31 | 8 | 37 | 51 | 68 |
Provision for Tax | 16 | 11 | 1 | 6 | 13 | 19 |
Profit After Tax | 20 | 19 | 6 | 31 | 38 | 50 |
Adjustments | 0 | 0 | 0 | 0 | 1 | 0 |
Profit After Adjustments | 20 | 20 | 6 | 32 | 39 | 50 |
Adjusted Earnings Per Share | 0 | 1.5 | 0.5 | 2.4 | 2.9 | 3.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 33% | 9% | 0% | 0% |
Operating Profit CAGR | 42% | 15% | 0% | 0% |
PAT CAGR | 23% | 26% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 124% | 98% | NA% | NA% |
ROE Average | 12% | 9% | 9% | 9% |
ROCE Average | 13% | 10% | 11% | 11% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 293 | 313 | 320 | 359 | 403 |
Minority's Interest | -0 | 0 | 2 | 2 | 5 |
Borrowings | 53 | 66 | 108 | 161 | 214 |
Other Non-Current Liabilities | 31 | 49 | 61 | 65 | 103 |
Total Current Liabilities | 177 | 158 | 118 | 138 | 206 |
Total Liabilities | 554 | 586 | 609 | 726 | 930 |
Fixed Assets | 381 | 393 | 383 | 489 | 605 |
Other Non-Current Assets | 61 | 76 | 116 | 110 | 155 |
Total Current Assets | 113 | 118 | 109 | 127 | 170 |
Total Assets | 554 | 586 | 609 | 726 | 930 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 4 | 9 | 12 | 19 | 16 |
Cash Flow from Operating Activities | 40 | 56 | 27 | 60 | 127 |
Cash Flow from Investing Activities | -50 | -26 | -37 | -107 | -158 |
Cash Flow from Financing Activities | 14 | -27 | 18 | 44 | 38 |
Net Cash Inflow / Outflow | 5 | 2 | 8 | -3 | 7 |
Closing Cash & Cash Equivalent | 9 | 12 | 19 | 16 | 23 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 1.5 | 0.49 | 2.4 | 2.88 |
CEPS(Rs) | 0 | 3.18 | 2.09 | 4.05 | 5.15 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0.45 |
Book NAV/Share(Rs) | 0 | 18.68 | 19.17 | 21.51 | 24.43 |
Core EBITDA Margin(%) | 11.68 | 10.88 | 8.62 | 11.98 | 12.74 |
EBIT Margin(%) | 8.74 | 7.69 | 5.01 | 8.86 | 9.53 |
Pre Tax Margin(%) | 6.72 | 5.42 | 1.84 | 6.7 | 6.86 |
PAT Margin (%) | 3.73 | 3.44 | 1.51 | 5.66 | 5.15 |
Cash Profit Margin (%) | 7.4 | 7.45 | 6.78 | 9.66 | 9.36 |
ROA(%) | 3.68 | 3.41 | 1.03 | 4.71 | 4.59 |
ROE(%) | 9.5 | 8.43 | 2.46 | 11.66 | 12.41 |
ROCE(%) | 13.96 | 12.64 | 5.63 | 11.47 | 13.34 |
Receivable days | 52.5 | 50.13 | 58.68 | 42.15 | 41.25 |
Inventory Days | 4.63 | 5.71 | 9.11 | 7.24 | 6.53 |
Payable days | 205.99 | 194.88 | 206.67 | 138.01 | 141.52 |
PER(x) | 0 | 9.23 | 45.31 | 19.1 | 23.65 |
Price/Book(x) | 0 | 0.74 | 1.16 | 2.13 | 2.79 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0.66 |
EV/Net Sales(x) | 0.19 | 0.47 | 0.96 | 1.38 | 1.5 |
EV/Core EBITDA(x) | 1.5 | 4.01 | 10.07 | 10.7 | 10.89 |
Net Sales Growth(%) | 0 | 3.39 | -27.72 | 35.85 | 32.92 |
EBIT Growth(%) | 0 | -9.04 | -52.9 | 140.33 | 42.97 |
PAT Growth(%) | 0 | -4.55 | -68.35 | 409.76 | 21.05 |
EPS Growth(%) | 0 | 0 | -67.23 | 390.47 | 19.75 |
Debt/Equity(x) | 0.53 | 0.4 | 0.5 | 0.64 | 0.74 |
Current Ratio(x) | 0.64 | 0.74 | 0.92 | 0.92 | 0.83 |
Quick Ratio(x) | 0.6 | 0.68 | 0.84 | 0.83 | 0.76 |
Interest Cover(x) | 4.34 | 3.39 | 1.58 | 4.11 | 3.57 |
Total Debt/Mcap(x) | 0 | 0.54 | 0.43 | 0.3 | 0.26 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 69.82 | 69.82 | 69.59 | 69.27 | 68.92 | 68.92 | 68.03 | 68.03 | 68.03 | 68.03 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.09 | 0.11 | 0.1 |
DII | 8.59 | 8.47 | 8.25 | 8.21 | 8.42 | 8.65 | 8.59 | 8.69 | 9.13 | 9.78 |
Public | 21.59 | 21.71 | 22.17 | 22.52 | 22.66 | 22.44 | 23.31 | 23.18 | 22.72 | 22.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 | 9.24 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.01 |
DII | 1.14 | 1.12 | 1.1 | 1.09 | 1.13 | 1.16 | 1.17 | 1.18 | 1.24 | 1.33 |
Public | 2.86 | 2.87 | 2.94 | 3 | 3.04 | 3.01 | 3.17 | 3.15 | 3.09 | 3 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13.24 | 13.24 | 13.28 | 13.34 | 13.41 | 13.41 | 13.59 | 13.59 | 13.59 | 13.59 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About